Salspera’s immunotherapy, Saltikva®, will provide new hope to patients and oncologists seeking therapeutic options without toxicity or side effects. In this Arch Beat episode, we talk to Salspera founders, Eddie Moradian and Dr. Daniel Saltzman about what they hope Saltikva® will do for patients and families.

The post Salspera Introduces new cancer treatment first appeared on StoneArch.